⌘K
t
Allergy Therapeutics plc conducted a Block Listing Interim Review for its 2013 Long Term Incentive Plan on August 2, 2022. For the period from February 1, 2022, to July 31, 2022, zero securities were issued under the plan. The balance of unallotted securities remained 7,118,772 at the end of the period, with no increase applied for since the last return.
| Date | 2 Aug 2022 |
| Time | 12:58:33 |
| Category | Capital structure |
| ID | 6513U |
Allergy Therapeutics plc
Block Listing Interim Review
Date 2 August 2022
|
Name of applicant: |
ALLERGY THERAPEUTICS PLC |
|||
|
Name of scheme: |
Allergy Therapeutics plc 2013 Long Term Incentive Plan |
|||
|
Period of return: |
From: |
1 February 2022 |
To: |
31 July 2022 |
|
Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission: |
10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017 |
|||
|
Balance of unallotted securities under scheme(s) from previous return: |
7,118,772 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period: |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
7,118,772 |
|||
|
Name of contact: |
Sara Goldsbrough |
|
Telephone number of contact: |
+44 (0) 7966 165719 |